These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10920757)

  • 1. Concordance between use of proton pump inhibitors and prescribing guidelines.
    Leditschke IA; Coombes JA
    Med J Aust; 2000 Jun; 172(11):564. PubMed ID: 10920757
    [No Abstract]   [Full Text] [Related]  

  • 2. Drugs for bleeding peptic ulcer.
    Netzer P; Inauen W
    Aliment Pharmacol Ther; 2002 Mar; 16(3):645-6. PubMed ID: 11876723
    [No Abstract]   [Full Text] [Related]  

  • 3. The changing role of H2-receptor antagonists in acid-related diseases.
    Lamers CB
    Eur J Gastroenterol Hepatol; 1996 Oct; 8 Suppl 1():S3-7. PubMed ID: 8930573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drugs used in the therapy of peptic ulcer with special reference to H2 receptor blockaders].
    De Natale G; De Natale F; Marino A
    Clin Ter; 1989 Apr; 129(1):3-16. PubMed ID: 2567647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis of and therapy for peptic ulcer].
    Terano A
    Nihon Naika Gakkai Zasshi; 2005 Feb; 94 Suppl():46-50. PubMed ID: 15796055
    [No Abstract]   [Full Text] [Related]  

  • 6. Towards an increased efficacy of acid inhibition in the treatment of erosive oesophagitis.
    Lambert R
    J Gastroenterol Hepatol; 1996 Oct; 11(10):897-9. PubMed ID: 8912122
    [No Abstract]   [Full Text] [Related]  

  • 7. [H2 receptor antagonists and proton pump inhibitors: principles and rules of use].
    Bardou M
    Rev Prat; 2001 Apr; 51(7):789-95. PubMed ID: 11387678
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical guidelines of diagnosis and treatment of gastroesophageal reflux disease].
    Rev Gastroenterol Mex; 2007; 72(2):163-76. PubMed ID: 17966380
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antisecretory therapy strategy for patients with bleeding and perforated gastroduodenal ulcers].
    Evseev MA; Ivakhov GB; Golovin RA
    Khirurgiia (Mosk); 2009; (3):46-52. PubMed ID: 19391208
    [No Abstract]   [Full Text] [Related]  

  • 10. Stress ulcer prevention and histamine-2-receptor antagonists: leaps of faith or back to the drawing board?
    Freedman MD
    Crit Care Med; 1999 Jan; 27(1):13-4. PubMed ID: 9934877
    [No Abstract]   [Full Text] [Related]  

  • 11. Overuse of acid-suppressive therapy in hospitalized patients.
    Nardino RJ; Vender RJ; Herbert PN
    Am J Gastroenterol; 2000 Nov; 95(11):3118-22. PubMed ID: 11095327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological efficacy of bismuth tripotassium dicitrate in peptic ulcer].
    Belousov IuB; Karpov OI; Belousov DIu; Beketov AS
    Ter Arkh; 2007; 79(2):58-66. PubMed ID: 17460971
    [No Abstract]   [Full Text] [Related]  

  • 13. Antisecretory therapy for bleeding peptic ulcer.
    Peterson WL; Cook DJ
    JAMA; 1998 Sep; 280(10):877-8. PubMed ID: 9739959
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug therapy of peptic ulcer disease.
    Ching CK; Lam SK
    Br J Hosp Med; 1995 Jul 12-Aug 15; 54(2-3):101-6. PubMed ID: 7551483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons].
    Holtmann G; Layer P; Goebell H
    Z Gastroenterol; 1996 May; 34(5):267-72. PubMed ID: 8686357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic options for the control of peptic ulcer disease.
    Levine JB
    Adv Intern Med; 1984; 30():425-47. PubMed ID: 6152108
    [No Abstract]   [Full Text] [Related]  

  • 17. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.
    Graham DY
    Am J Med; 2001 Jan; 110(1A):58S-61S. PubMed ID: 11166000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study).
    Treiber G; Wittig J; Ammon S; Walker S; van Doorn LJ; Klotz U
    Arch Intern Med; 2002 Jan; 162(2):153-60. PubMed ID: 11802748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-dependent eradication of Helicobacter pylori with dual therapy.
    Treiber G; Ammon S; Klotz U
    Aliment Pharmacol Ther; 1997 Aug; 11(4):711-8. PubMed ID: 9305480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Guidelines for good practice: anti-ulcer agents, indications in the adult. French Agency for Health Safety of Health Products].
    Therapie; 1999; 54(5):509-17. PubMed ID: 10667082
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.